Olympic champion Caster Semenya must take drugs to suppress her testosterone levels to compete again in certain women's track races, the highest court in international sports ruled.
Olympic track champion Caster Semenya must take drugs to suppress her testosterone levels to compete again in certain women's races, the highest court in international sports ruled.
Semenya, a mid-distance meter track star from South Africa, who won the gold in the 800-meter races at the 2012 and 2016 Olympics, has had her gender and hormone levels highly scrutinized over the years. The IAAF in a split 2-1 decision said the rules are"a justified and proportionate means of ensuring consistent treatment, and preserving fair and meaningful competition" among women, according to a release from the arbitration court Wednesday.
But she lost the appeal as the sports high court's panel determined that elevated testosterone in females gives women a competitive advantage in certain races shorter than one mile, such as the 400-meter and the 800-meter races in which Semenya competes.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Olympic champion Semenya loses appeal over testosterone rulesOlympic 800-metres champion Caster Semenya on Wednesday lost her appeal against ...
Weiterlesen »
Semenya loses appeal against IAAF testosterone rulesThe IAAF believes female runners with high testosterone levels have an unfair advantage in events from 400 meters to the mile.
Weiterlesen »
Olympic champion Caster Semenya loses landmark case on testosterone levelsCaster Semenya has had an appeal dismissed by CAS to halt the introduction of regulations which will limit testosterone in female athletes with differences in sexual development.
Weiterlesen »
Olympic gold medalist loses gender appeal, casting doubt on futureOlympic gold medalist Caster Semenya loses landmark gender appeal, casting doubt on future competition
Weiterlesen »
Caster Semenya loses appeal: track federation may regulate women with naturally high testosterone levelsSouth African runner Caster Semenya has lost her appeal against track officials who may now proceed to judge female athletes by their body chemistry.
Weiterlesen »
Olympic gold medalist Caster Semenya loses landmark gender appeal, casting doubt on future competitionFemale track star Caster Semenya has lost her appeal in court against a gender ruling that restricts the amount of testosterone female athletes can have in their bodies in order to compete. The South African Semenya, 28, an Olympic gold medallist, was seeking to overturn the 'discriminatory'
Weiterlesen »
Caster Semenya loses landmark testosterone rule caseDouble Olympic champion Caster Semenya has lost her appeal against the introduction of new rules regulating the testosterone levels for athletes with a difference in sex development (DSD).
Weiterlesen »
Caster Semenya loses appeal in controversial case over IAAF's testosterone rulesSemenya, a two-time Olympic champion in the 800 meters, will now be forced to medicate to suppress her testosterone levels if she wants to defend her world title.
Weiterlesen »
Perspective | Caster Semenya ruling shows how far we have to go in understanding genderPerspective: To compete in the biggest track events, Caster Semenya has to take medications to decrease her testosterone level. If she declines, she can't compete on the grandest stage. The ruling shows how far we have to go in understanding gender.
Weiterlesen »
Court says Olympian Caster Semenya, thought to have an intersex condition, cannot compete unless she uses hormone-suppressing drugsThe Court of Arbitration for Sport issued the ruling related to the South African middle-distance runner, who is thought to have an intersex condition that causes her body to produce increased testosterone. The International Association of Athletics Federations, the world governing body for track and field, had previously instituted rules that precluded Semenya from competing […]
Weiterlesen »